Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats
- PMID: 21309953
- PMCID: PMC3178679
- DOI: 10.1111/j.1369-1600.2010.00291.x
Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats
Abstract
Alcoholism is a devastating condition that represents a progression from initial alcohol use to dependence. Although most individuals are capable of consuming alcohol in a limited fashion, the development of alcohol dependence in a subset of individuals is often associated with negative emotional states (including anxiety and depression). Since the alleviation of this negative motivational state via excessive alcohol consumption often becomes a central goal of alcoholics, the transition from initial use to dependence is postulated to be associated with a transition from positive to negative reinforcement mechanisms. Vasopressin is a neuropeptide known to potentiate the effects of CRF on the HPA axis, and emerging evidence also suggests a role for centrally located vasopressin acting on V(1b) receptors in the regulation of stress- and anxiety-like behaviors in rodents. The present study determined state-dependent alterations in vasopressin/V(1b) R signaling in an animal model of ethanol dependence. The V(1b) R antagonist SSR149415 dose-dependently reduced excessive levels of ethanol self-administration observed in dependent animals without affecting the limited levels of ethanol drinking in non-dependent animals. Ethanol self-administration reduced V(1b) receptor levels in the basolateral amygdala of non-dependent animals, a neuroadaptation that could theoretically facilitate the positive reinforcing effects of alcohol. In contrast, V(1b) R levels were seemingly restored in ethanol-dependent rats, a switch that may in part underlie a transition from positive to negative reinforcement mechanisms with dependence. Together, our data suggest a key role for vasopressin/V(1b) R signaling in the transition to ethanol dependence.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3178679/bin/nihms251838f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3178679/bin/nihms251838f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3178679/bin/nihms251838f3.gif)
Similar articles
-
Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.Alcohol Clin Exp Res. 2011 Oct;35(10):1876-83. doi: 10.1111/j.1530-0277.2011.01532.x. Epub 2011 May 16. Alcohol Clin Exp Res. 2011. PMID: 21575018 Free PMC article.
-
Alcohol Dependence Disrupts Amygdalar L-Type Voltage-Gated Calcium Channel Mechanisms.J Neurosci. 2017 Apr 26;37(17):4593-4603. doi: 10.1523/JNEUROSCI.3721-16.2017. Epub 2017 Mar 31. J Neurosci. 2017. PMID: 28363981 Free PMC article.
-
Systemic Administration of the Cyclin-Dependent Kinase Inhibitor (S)-CR8 Selectively Reduces Escalated Ethanol Intake in Dependent Rats.Alcohol Clin Exp Res. 2019 Oct;43(10):2079-2089. doi: 10.1111/acer.14177. Epub 2019 Aug 30. Alcohol Clin Exp Res. 2019. PMID: 31403700 Free PMC article.
-
An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.CNS Drug Rev. 2005 Spring;11(1):53-68. doi: 10.1111/j.1527-3458.2005.tb00035.x. CNS Drug Rev. 2005. PMID: 15867952 Free PMC article. Review.
-
A role for GABA mechanisms in the motivational effects of alcohol.Biochem Pharmacol. 2004 Oct 15;68(8):1515-25. doi: 10.1016/j.bcp.2004.07.031. Biochem Pharmacol. 2004. PMID: 15451394 Review.
Cited by
-
Methylation of the Oxytocin, Oxytocin Receptor, and Vasopressin Gene Promoters in Tobacco Use Disorder during Cessation.Neuropsychobiology. 2024;83(1):28-40. doi: 10.1159/000535663. Epub 2024 Jan 5. Neuropsychobiology. 2024. PMID: 38185116 Free PMC article.
-
The Role of Oxytocin and Vasopressin in Drug-Induced Reward-Implications for Social and Non-Social Factors.Biomolecules. 2023 Feb 21;13(3):405. doi: 10.3390/biom13030405. Biomolecules. 2023. PMID: 36979340 Free PMC article. Review.
-
Agmatine reduces alcohol drinking and produces antinociceptive effects in rodent models of alcohol use disorder.Alcohol. 2023 Jun;109:23-33. doi: 10.1016/j.alcohol.2023.01.003. Epub 2023 Jan 26. Alcohol. 2023. PMID: 36709008 Free PMC article.
-
Impact of adolescent intermittent ethanol exposure in male and female rats on social drinking and neuropeptide gene expression.Alcohol Clin Exp Res. 2022 Jun;46(6):979-993. doi: 10.1111/acer.14847. Epub 2022 May 2. Alcohol Clin Exp Res. 2022. PMID: 35470441 Free PMC article.
-
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.Drugs. 2022 Feb;82(3):251-274. doi: 10.1007/s40265-021-01670-3. Epub 2022 Feb 8. Drugs. 2022. PMID: 35133639 Free PMC article. Review.
References
-
- Aguilera G, Rabadan-Diehl C. Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Experimental Physiology. 2000;85(19S–26S) - PubMed
-
- Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology. 1993;14:76–122. - PubMed
-
- Beard JD, Sargent WQ. Water and electrolyte metabolism following ethanol intake and during acute withdrawal from ethanol. In: Majchrowicz E, Noble EP, editors. Biochemistry and Pharmacology of Ethanol. Vol. 2. New York: Plenum Press; 1979. pp. 3–16.
-
- Brownstein MJ, Russell JT, Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science. 1980;207:373–378. - PubMed
-
- Buijs RM. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord. Cell & Tissue Research. 1978;192:423–435. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 AA007456-29/AA/NIAAA NIH HHS/United States
- AA12602/AA/NIAAA NIH HHS/United States
- P60 AA006420-29/AA/NIAAA NIH HHS/United States
- R37 AA008459/AA/NIAAA NIH HHS/United States
- R01 AA008459-22/AA/NIAAA NIH HHS/United States
- F32 AA018250/AA/NIAAA NIH HHS/United States
- F32 AA018250-01/AA/NIAAA NIH HHS/United States
- F32 AA018250-02/AA/NIAAA NIH HHS/United States
- P60 AA006420/AA/NIAAA NIH HHS/United States
- AA008459/AA/NIAAA NIH HHS/United States
- F32 AA018250-03/AA/NIAAA NIH HHS/United States
- T32 AA007456/AA/NIAAA NIH HHS/United States
- R01 AA012602/AA/NIAAA NIH HHS/United States
- R01 AA008459/AA/NIAAA NIH HHS/United States
- AA018250/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical